- Home
- CTM vs CLYM Comparison
CTM vs CLYM Comparison
Compare CTM & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTM
- CLYM
- Stock Information
- Founded
- CTM 2019
- CLYM 2018
- Country
- CTM United States
- CLYM United States
- Employees
- CTM N/A
- CLYM 18
- Industry
- CTM EDP Services
- CLYM
- Sector
- CTM Technology
- CLYM
- Exchange
- CTM Nasdaq
- CLYM NYSE
- Market Cap
- CTM 101.5M
- CLYM 86.5M
- IPO Year
- CTM N/A
- CLYM 2021
- Fundamental
- Price
- CTM $1.05
- CLYM $1.22
- Analyst Decision
- CTM Strong Buy
- CLYM Buy
- Analyst Count
- CTM 1
- CLYM 1
- Target Price
- CTM $3.00
- CLYM $10.00
- AVG Volume (30 Days)
- CTM 2.1M
- CLYM 200.0K
- Earning Date
- CTM 08-08-2025
- CLYM 08-13-2025
- Dividend Yield
- CTM N/A
- CLYM N/A
- EPS Growth
- CTM N/A
- CLYM N/A
- EPS
- CTM N/A
- CLYM N/A
- Revenue
- CTM $45,094,164.00
- CLYM N/A
- Revenue This Year
- CTM $22.97
- CLYM N/A
- Revenue Next Year
- CTM $3.76
- CLYM N/A
- P/E Ratio
- CTM N/A
- CLYM N/A
- Revenue Growth
- CTM N/A
- CLYM N/A
- 52 Week Low
- CTM $0.12
- CLYM $1.05
- 52 Week High
- CTM $2.83
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- CTM 45.48
- CLYM N/A
- Support Level
- CTM $1.15
- CLYM N/A
- Resistance Level
- CTM $1.44
- CLYM N/A
- Average True Range (ATR)
- CTM 0.10
- CLYM 0.00
- MACD
- CTM -0.02
- CLYM 0.00
- Stochastic Oscillator
- CTM 17.19
- CLYM 0.00
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.